The Corporate Governance Officer reports the communications with stakeholders to the Board of Directors annually. The communications with stakeholders including feedbacks from stakeholders, responses and follow-up response plans have been reported to the Board of Directors on August 7, 2024.
Stakeholders | Main party | Key Focus Areas | Responses | Communication Performance in 2024 |
---|---|---|---|---|
Shareholders/ Investors |
|
|
|
|
Employees | All Employees |
|
|
|
Clients |
|
|
|
|
Suppliers and Contractors |
|
|
|
|
Media outlets |
|
|
|
|
Competent Authorities | Government |
|
|
|
Spokesperson: Ted Kao
Title: Chief Financial Officer
Phone: 02-2655-8525 #5154
Email: ted_kao@tshbiopharm.com
Deputy Spokesperson and Investor Relations Contact: Shuping Huang
Title: Manager of Administration Department
Phone: 02-2655-8525 #5105
Email: Shupinghuang@tshbiopharm.com
Email: ethical@tshbiopharm.com
Contact: Jessica Wu
Title: Chief Internal Auditor
Phone: 02-2655-8525 #5523
Email: Jessica_wu@tshbiopharm.com
Contact: Han Hsieh
Title: Director of Corporate Development and Research
Phone: 02-2655-8525 #5412
Email: han_hsieh@tshbiopharm.com
Contact: Eliza Chang
Title: Senior Specialist
Phone: 02-2655-8525 #5131
Email: eliza@tshbiopharm.com
Contact: Isa Wang
Title: Assistant Manager
Phone: 02-2655-8525 #5111
Email: isa_wang@tshbiopharm.com